This test is most useful if any of these apply to you.
You can have a normal cholesterol panel, normal blood sugar, and normal kidney numbers, and still be quietly building up the one molecule that triggers gout attacks, fuels kidney stones, and tracks closely with heart attack and stroke risk. Uric acid is not part of a standard metabolic panel, which means most people have never seen their number even after years of routine blood work.
Uric acid is the end product of how your body breaks down purines, the building blocks found in cells and in certain foods. Knowing your level gives you a single, low-cost read on three different problems at once: your risk of gout, how hard your kidneys are working to clear waste, and a piece of your cardiovascular risk picture that cholesterol cannot show.
Your body makes uric acid in the liver, intestines, and the lining of your blood vessels whenever cells die and recycle their genetic material. Roughly two thirds of that uric acid leaves through your kidneys and one third through your gut. The kidneys actually filter out far more than they release, sending only about 8 to 12 percent of the filtered amount into your urine and pulling the rest back. The number on your lab report reflects the balance between how much you make and how much you clear.
A high level (hyperuricemia) means you are either producing too much, clearing too little, or both. Common drivers are kidney disease, metabolic syndrome, diuretics, alcohol, and diets heavy in red meat, organ meats, seafood, and sugar-sweetened drinks. A very low level can be a sign of certain inherited kidney conditions, severe protein loss, or simply the result of recent surgery or acute illness.
At roughly 6.8 mg/dL, uric acid starts to crystallize out of solution. Those needle-shaped crystals are what cause the screaming pain of a gout attack, the lumps under the skin called tophi, and many uric acid kidney stones. The higher your level climbs above this saturation point, the more crystals accumulate in your joints and soft tissue, often silently, for years before the first attack.
Hyperuricemia alone does not guarantee gout. In long-term observational data, most people with markedly elevated levels still did not develop a clinical gout attack over 15 years, though roughly half of those with severe hyperuricemia (uric acid at or above 10 mg/dL) eventually did. The relationship runs the other direction too: during an active flare, inflammation can temporarily push your serum level down into the normal range, which is why a single reading during pain cannot rule gout in or out. The reverse is also true: a single elevated reading does not confirm gout. The gold-standard diagnosis still requires looking at joint fluid under a microscope and seeing the crystals directly.
Uric acid tracks with cardiovascular risk in a way that cholesterol cannot fully capture. In a 2025 dose-response meta-analysis of more than one million participants across dozens of studies, each 1 mg/dL increase in serum uric acid was associated with a meaningful rise in coronary heart disease risk and cardiovascular death. People with hyperuricemia were also more likely to develop coronary heart disease and to die from cardiovascular disease compared with people who did not have hyperuricemia.
Stroke risk follows the same pattern. In a meta-analysis of 19 prospective cohorts covering tens of thousands of people, each 1 mg/dL increase in uric acid was tied to a higher risk of total stroke, ischemic stroke, and hemorrhagic stroke. The link was consistently stronger in women than in men.
The URRAH study of more than 22,000 adults followed for two decades identified thresholds where mortality risk starts to climb meaningfully, both well below the traditional clinical cutoff for hyperuricemia. A separate large Japanese cohort found a J-shaped relationship: risk rises both at very low and very high levels, with the curve bending upward at different points for men and women.
The fact that both very low and very high uric acid carry higher mortality risk is not a contradiction. Very low levels often reflect serious underlying illness: acute infection, severe malnutrition, advanced liver disease, or specific kidney problems that waste urate into the urine. The low number is a signal of the illness, not a sign of vibrant health. Very high levels reflect a different problem: overproduction or underexcretion that drives crystal disease and tracks with metabolic and vascular damage. The sweet spot is in the middle, where the level sits comfortably below the crystal saturation point without dipping into the territory associated with acute illness or wasting.
Your kidneys clear most of your uric acid, so anything that damages kidney filtration shows up here. A meta-analysis of 15 cohorts covering nearly 100,000 people found that each 1 mg/dL rise in uric acid was associated with a meaningfully higher risk of developing chronic kidney disease. A larger 2021 meta-analysis of 30 cohort studies came to a similar conclusion, with people in the highest uric acid group running notably higher risk than those in the lowest. The connection is bidirectional: failing kidneys clear less uric acid, which then accumulates and may further damage the kidneys.
Uric acid kidney stones are the other half of the kidney story. Persistently acidic urine plus high uric acid concentration encourages stone formation. If you have had a stone, knowing your serum uric acid is essential to figure out whether you are dealing with a uric acid stone, a calcium stone, or something else.
In a meta-analysis of 25 studies covering nearly 100,000 people, hyperuricemia was tied to a substantially higher risk of developing high blood pressure, and each 1 mg/dL rise carried an incremental risk increase. The link was strongest in younger adults, where elevated uric acid often shows up years before blood pressure starts to drift.
For heart failure, a meta-analysis found people with hyperuricemia were significantly more likely to develop heart failure, with each 1 mg/dL rise increasing the odds further. In a separate Chinese cohort of more than 18,000 adults with established cardiovascular disease, those in the highest uric acid tertile had a substantially higher risk of developing heart failure compared with the lowest tertile over six years of follow-up.
| Outcome | What the Evidence Shows | Population Studied |
|---|---|---|
| Coronary heart disease | Higher risk in people with hyperuricemia, with each 1 mg/dL rise adding incremental risk | More than one million adults across dozens of studies |
| Stroke | Higher risk per 1 mg/dL increase, stronger in women | Tens of thousands of adults across 19 cohorts |
| Chronic kidney disease | Higher risk per 1 mg/dL rise | Nearly 100,000 middle-aged adults across 15 cohorts |
| Heart failure | Substantially higher risk with hyperuricemia, with further increases per 1 mg/dL | Multiple prospective cohorts |
| High blood pressure | Substantially higher risk with hyperuricemia, with incremental risk per 1 mg/dL | Nearly 100,000 adults across 25 studies |
Sources: Lyu et al. 2025 (coronary heart disease), Qiao et al. 2021 (stroke), Zhu et al. 2014 (chronic kidney disease), Huang et al. 2014 (heart failure), Wang et al. 2014 (hypertension).
What this means for you: even if you do not have gout symptoms, uric acid gives you a forward-looking read on multiple disease pathways at once. A rising trend deserves the same attention you would give a creeping LDL or a slowly worsening fasting glucose.
Uric acid has a within-person variability of roughly 5 to 9 percent, with measurable differences between men and women, meaning two readings on the same person taken days or weeks apart can differ by that much for reasons that have nothing to do with disease. Levels can also vary noticeably across the day, with morning values often higher than afternoon ones, especially in people with diabetes. A single number is a snapshot. A trend is the real signal.
Get a baseline now. If you are making changes such as cutting back on sugar-sweetened drinks, losing weight, switching from a thiazide diuretic, or starting urate-lowering medication, retest in 3 to 6 months to see whether the number is actually moving. Once you have a stable result, retest at least once a year. If you are already on urate-lowering therapy, more frequent monitoring is reasonable until you confirm you are below the saturation threshold. Tracking lets you distinguish a one-time spike (a big steak dinner the night before) from a real shift in your underlying physiology.
A few factors can move your number in ways that have nothing to do with the long-term picture. Lead with what is most likely to throw off a single reading:
If your number comes back elevated and you have no symptoms, the first move is to retest in a few weeks under conditions that minimize confounders: no recent intense workout, similar time of day, similar meal pattern the day before. If the elevation is confirmed, the workup widens. Pair it with kidney function (creatinine, cystatin C, eGFR), a metabolic panel, fasting lipids, fasting glucose or HbA1c, and a blood pressure reading. The combination tells you whether this is an isolated finding or one piece of a broader metabolic pattern.
If you have had a joint flare, a kidney stone, or known cardiovascular disease, an elevated uric acid is meaningful clinical information and a rheumatologist or nephrologist can help decide whether to start urate-lowering therapy. If you have asymptomatic hyperuricemia plus chronic kidney disease, hypertension, or established cardiovascular disease, the case for tighter monitoring and lifestyle change is strong even if drug therapy is not yet on the table. A persistently low result calls for a different investigation, focused on kidney urate handling and possible protein loss.
The pattern matters more than any single number. A high reading in the context of normal kidneys and no other risk factors is a different conversation from the same reading in someone with creeping creatinine, rising blood pressure, and a family history of gout.
Evidence-backed interventions that affect your Uric Acid level
Uric Acid is best interpreted alongside these tests.
Uric Acid is included in these pre-built panels.